Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3199 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2934 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
12 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2023-07-11 | 2024-09-05 | 198303 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Resolved | 2023-07-11 | 2024-06-27 | 198306 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Resolved | 2023-07-11 | 2024-07-11 | 198309 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2023-08-17 | 2024-09-05 | 202252 |
| TEVA-SIMVASTATIN | 10MG | TABLET | Resolved | 2023-10-05 | 2024-07-04 | 206401 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-10-19 | 2024-07-18 | 207518 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2024-01-11 | 2024-07-04 | 215722 |
| TEVA-SIMVASTATIN | 10MG | TABLET | Actual shortage | 2025-11-27 | 2025-12-18 | 272763 |
| TEVA-SITAGLIPTIN MALATE | 25MG | TABLET | Actual shortage | 2025-03-06 | 2025-12-12 | 252059 |
| TEVA-SITAGLIPTIN MALATE | 50MG | TABLET | Actual shortage | 2025-03-06 | 2025-12-12 | 252062 |
| TEVA-SITAGLIPTIN MALATE | 100MG | TABLET | Actual shortage | 2025-03-06 | 2025-12-12 | 252066 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2017-08-02 | 2017-09-19 | 18017 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2019-09-05 | 2020-04-09 | 93149 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94861 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-11-28 | 2020-04-02 | 99944 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-01-17 | 2020-04-02 | 103555 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2020-01-24 | 2020-06-05 | 104330 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-07-09 | 2020-09-03 | 119895 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2021-11-11 | 2022-04-21 | 149113 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2021-12-17 | 2024-05-30 | 151465 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CAPTOPRIL | 25MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258556 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
| TEVA-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258759 |
| TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117526 |
| TEVA-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117529 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Discontinued | 2025-04-25 | 2025-04-25 | 255815 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
| TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103791 |